9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7776 | ADH-503 | GB1275 | Complement System |
ADH-503 (GB1275) is a potent agonist of the integrin CD11b to mitigate myeloid cell immunosuppression. | |||
T13379 | (Z)-Leukadherin-1 | ADH-503 free base | Complement System |
(Z)-Leukadherin-1 (ADH-503 free base) is an allosteric agonist of CD11b. | |||
T26699 | AZ10397767 | AZ 10397767,AZ-10397767 | |
AZ10397767 is a potent CXCR2 antagonist (IC50 = 1 nM). AZ10397767 significantly reduced the numbers of infiltrating neutrophils into both in vitro and in vivo tumor models. | |||
T79528 | SWS1 | PD-1/PD-L1 | |
SWS1, a d-(+)-biotin-conjugated PD-L1 inhibitor (IC50: 1.8 nM), displays anticancer activity by augmenting tumor-infiltrating lymphocytes and demonstrating anti-tumor efficacy, as evidenced by a 66.1% tumor growth inhibi... | |||
T76410 | Tyrosinase (206-214), human | ||
Tyrosinase (206-214), human (AFLPWHRLF), is a 9-amino acid peptide and an epitope of tyrosinase that can be recognized by HLA-A24 restricted, tumor-infiltrating lymphocytes (TIL) [1]. | |||
T71890 | F5446 | ||
F5446 is a SUV39H1 inhibitor. F5446 has an EC50 of 0.496 μmol/L for SUV39H1 enzymatic activity. H3K9me3 was enriched in the promoters of GZMB, PRF1, FASLG, and IFNG in quiescent T cells. F5446 inhibited H3K9me3, thereby ... | |||
T77090 | Mitazalimab | ||
Mitazalimab (ADC-1013; JNJ-64457107) is an FcγR-dependent CD40 agonist that exhibits directed activity against tumors. By activating antigen-presenting cells, such as dendritic cells (DC), it triggers the initiation of t... | |||
T70928 | CB-1158-analog | ||
CB-1158-analog, also known as Numidargistat-analog and INCB01158-analog, is a potent and orally active arginase inhibitor with IC50=89 nM) . CB-1158 blocked myeloid cell-mediated suppression of T cell proliferation in vi... | |||
T78053 | PD-L1-IN-2 | PD-1/PD-L1 | |
PD-L1-IN-2, a Naamidine J derivative, serves as a promising antineoplastic immunomodulator by hindering PD-L1 activity. In vivo studies indicate that it suppresses PD-L1 expression and amplifies tumor-infiltrating T-cell... |